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Introduction
The timing of valve surgery in asymptomatic patients
with significant aortic regurgitation can be challenging.
Current indications focus on symptoms and left ventri-
cular (LV) dilation/dysfunction, but prognosis is already
reduced by this time. Quantification of the regurgitation
has not previously been used to guide management,
likely due to the difficulty of achieving this with echo-
cardiography. Cardiovascular magnetic resonance
(CMR) can accurately quantify aortic regurgitation and
LV volumes, and we examined whether either could
predict symptom development and the need for aortic
valve surgery.
Methods
94 asymptomatic patients with moderate or severe aortic
regurgitation on echocardiography were identified from
four high volume CMR centres. CMR was performed to
quantify aortic regurgitation and LV volume indices,
and subsequent clinical follow up occurred for up to
7 years (mean 2.6 ±2.1 years). The best predictors of
progression to symptoms and other conventional indica-
tions for surgery were determined.
Results
Aortic regurgitant fraction was the best predictor of
clinical outcome; area under the curve (AUC) on recei-
ver operating characteristics analysis 0.93 (p<0.0001),
with a specificity of 93% and sensitivity of 78% for pre-
dicting the progression to symptoms and surgery. Survi-
val without surgery was 88% for patients with a
regurgitant fraction <37%, compared to 6% for those
with a regurgitant fraction ≥37% (see figure 1). Regurgi-
tant volume >38mls and regurgitant volume index
>25mls/m2 were also good predictors (AUC 0.91 and
0.90 respectively), though regurgitant fraction had signif-
icantly greater predictive power (odds ratio 1.26 com-
pared to 1.09 for regurgitant volume). LV volumetric
indices also predicted outcome, but less strongly than
measures of regurgitation: LV end-diastolic volume
>267mls (AUC 0.85), LV end-systolic volume >88mls
(AUC 0.78). Regurgitant fraction and volume were the
only independent outcome predictors on multiple logis-
tic regression analysis. The predictive ability of CMR
applied to patients with both moderate and severe aortic
regurgitation on echocardiography. Supporting data also
comes from a comparison with patients already planning
to undergo surgery at the time of CMR scanning, which
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showed similar regurgitant fractions in the surgical
group (mean ±SD: 45.4 ±12.1%) compared to the initi-
ally asymptomatic patients who developed symptoms or
other indications for surgery (42.8 ±10.4%); p=0.32. Sub-
jects who remained asymptomatic had a significantly
lower regurgitant fraction: 25.3 ±8.6% (p<0.0001 vs.
both the planned surgical group and the symptom pro-
gression group)
Conclusions
CMR quantification of aortic regurgitation and LV
volumes accurately predicts the progression to symp-
toms/surgery. Its use in patients with aortic regurgita-
tion should be encouraged.
Author details
1University of Oxford Centre for Clinical Magnetic Resonance Research
(OCMR), Oxford, UK. 2University of Leeds, Leeds, UK. 3CMR Unit, Royal
Brompton Hospital and National Heart and Lung Institute, London, UK.
4John Radcliffe Hospital, Oxford, UK. 5North Shore Hospital, Auckland,
New Zealand.
Published: 2 February 2011
doi:10.1186/1532-429X-13-S1-O99
Cite this article as: Myerson et al.: CMR quantification of aortic
regurgitation in asymptomatic patients with significant aortic
regurgitation: prediction of clinical outcome. Journal of Cardiovascular
Magnetic Resonance 2011 13(Suppl 1):O99.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Myerson et al. Journal of Cardiovascular Magnetic Resonance 2011, 13(Suppl 1):O99
http://jcmr-online.com/content/13/S1/O99
Page 2 of 2
